Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3QKK

Spirochromane Akt Inhibitors

Summary for 3QKK
Entry DOI10.2210/pdb3qkk/pdb
Related3OCB 3QKL 3QKM
DescriptorRAC-alpha serine/threonine-protein kinase, Glycogen synthase kinase-3 beta, N-(2-ethoxyethyl)-N-{(2S)-2-hydroxy-3-[(2R)-6-hydroxy-4-oxo-3,4-dihydro-1'H-spiro[chromene-2,3'-piperidin]-1'-yl]propyl}-2,6-dimethylbenzenesulfonamide, ... (4 entities in total)
Functional Keywordskinase domain, transferase-transferase inhibitor complex, transferase/transferase inhibitor
Biological sourceHomo sapiens (human)
More
Cellular locationCytoplasm: P31749
Total number of polymer chains2
Total formula weight41136.86
Authors
Primary citationKallan, N.C.,Spencer, K.L.,Blake, J.F.,Xu, R.,Heizer, J.,Bencsik, J.R.,Mitchell, I.S.,Gloor, S.L.,Martinson, M.,Risom, T.,Gross, S.D.,Morales, T.H.,Wu, W.I.,Vigers, G.P.,Brandhuber, B.J.,Skelton, N.J.
Discovery and SAR of spirochromane Akt inhibitors.
Bioorg.Med.Chem.Lett., 21:2410-2414, 2011
Cited by
PubMed Abstract: A novel series of spirochromane pan-Akt inhibitors is reported. SAR optimization furnished compounds with improved enzyme potencies and excellent selectivity over the related AGC kinase PKA. Attempted replacement of the phenol hinge binder provided compounds with excellent Akt enzyme and cell activities but greatly diminished selectivity over PKA.
PubMed: 21392984
DOI: 10.1016/j.bmcl.2011.02.073
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.3 Å)
Structure validation

247947

PDB entries from 2026-01-21

PDB statisticsPDBj update infoContact PDBjnumon